| 
              About What Global Medtech 
              Manufacturers Need To Copy From India and China 
                
              Gone are the days when European or 
              U.S. manufacturers would simply take products designed for use in 
              high-end markets, reduce the features and, consequently, make them 
              cheaper for emerging markets. 
                
              This kind of minor adaptation is not 
              working any more. Instead Western Companies need to rethink 
              products with local conditions in mind. 
                
              Chinese and Indian companies have 
              understood the opportunities in their markets and have been 
              innovating for this segment building “good enough” solutions for 
              down to 10% of the costs of western products. The core of this 
              frugal innovation is to limit a product to essential features and 
              use of off-the-shelf components whenever possible. Rather than 
              pushing a technology to the market, western companies need to 
              “work backwards” from the market, producing only devices the 
              customers are able to pay for. 
                
              GE’s John H. Welch Technology center 
              in Bangalore, for instance, developed an electrocardiogram (ECG) 
              device for the local market costing less than a tenth of a similar 
              device in developed countries. “Traditionally they would build it 
              in-house, develop all the technology from scratch with high 
              quality standards. Instead, they copied domestic competitors using 
              off-the-shelf components, The device needed a Printer, for 
              example, so researchers used a bus ticket printer. For the keypad 
              they used a component from a telephone.” 
                
              But the benefit doesn’t end with the 
              emerging market, thanks to reverse innovation. After being 
              developed for India, the device now has FDA approval and is used 
              in the U.S. for emergency applications. There are already products 
              succeeding in Western markets that were originally developed for 
              emerging countries. 
                
              (Based On Interview given by Prof. 
              Jaideep Prabhu, Cambridge Centre for India and Global Business, to 
              EMDT; Ref. link :
              
              http://www.emdt.co.uk/daily-buzz/reverseinnovation-what-medtech-manufacturers-need-copy-chinese-and-indiancompanies 
              )
 
              *  *  *  *  * |